Literature DB >> 21283320

Resistant hypertension: evaluation of the patient.

E C Abbott.   

Abstract

Resistant hypertension is a common and serious problem. Before major changes in management are undertaken, seven questions should be asked: 1. What is a realistic goal blood pressure? 2. Is the erect blood pressure below the goal? 3. Is the patient compliant? 4. Does the patient have `office hypertension'? 5. Is the patient using medication which aggravates hypertension? 6. Are there confounding renal or cardiovascular responses to medication? 7. Has a secondary cause of hypertension been overlooked? Newer and more potent medications such as captopril and minoxidil should be recommended only after exploration of these questions and after careful clinical and laboratory evaluation.

Entities:  

Year:  1983        PMID: 21283320      PMCID: PMC2153754     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  5 in total

1.  The hypertensive patient: 5. Compliance with therapy.

Authors:  D L Sackett
Journal:  Can Med Assoc J       Date:  1979-08-04       Impact factor: 8.262

2.  Massachusetts Department of Public Health. Risk factors and life style: a statewide health-interview survey.

Authors:  C A Lambert; D R Netherton; L J Finison; J N Hyde; S J Spaight
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

3.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.

Authors:  J Watkins; E C Abbott; C N Hensby; J Webster; C T Dollery
Journal:  Br Med J       Date:  1980-09-13

4.  Alcohol consumption and blood pressure. Kaiser-Permanente Multiphasic Health Examination data.

Authors:  A L Klatsky; G D Friedman; A B Siegelaub; M J Gérard
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

5.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.